How AI Search Is Recommending Weight Loss and Metabolic Health: Monthly Trends

Executive Summary

WeightWatchers holds the category lead in October 2026 with 54.1% valid recommendation coverage, up 7.2 points from 46.9% in September 2026 and up 12.9 points from the July 2026 baseline of 41.2%. The benchmark classifies WeightWatchers as a significant riser this month. Noom holds second place at 49.4% coverage, putting the top-two gap at 4.7 points in October 2026.

Ro matches Noom at 49.4% coverage in October 2026, tied for second on the primary metric. The brand rose from zero coverage in July and August 2026 through 32.9% in September 2026 to 49.4% in October 2026, a 49.4-point gain from baseline that the benchmark classifies as a significant riser. Found is the month's largest single-month mover, up 13.5 points from 24.5% in September 2026 to 38.0% in October 2026, also classified as a significant riser.

Ro (Roman), the entity tracked under that name in July and August 2026 at 17.6% and 18.4% coverage, recorded zero coverage for the second consecutive month and remains classified as a significant decliner against the July 2026 baseline. GNC holds 2.4% coverage, down 4.1 points from 6.5% in July 2026, a change the benchmark does not classify as significant across the four-month series.

Five brands are classified as significant risers this month (Found, Hims, LifeMD, Ro, and WeightWatchers), one as a significant decliner (Ro (Roman)), and four as stable (GNC, Herbalife, Noom, and Vitamin Shoppe). The category summary records the month as mixed with significant movement.

Each monthly run begins with 800 prompt-surface observations across the benchmark's defined AI/search surface universe. In July 2026 there were 723 unique questions, with 800 mentioning a tracked brand or competitor, 298 relevant and 502 irrelevant. In October 2026 there were 717 unique questions, with 800 mentioning a tracked brand or competitor, 495 relevant and 305 irrelevant. The public metrics use the observations that survive both qualification stages: 170 in July 2026 and 255 in October 2026. Intermediate months recorded 190 qualified observations in August 2026 and 286 in September 2026.

Key Findings

AI Response Inconsistency Alerts

Questions This Section Answers

• Where did AI platforms give conflicting answers about weight loss programs and medications?
• Which factual conflicts did the benchmark flag as critical or high severity?

Four critical or high-severity factual inconsistencies were detected across four AI platforms (Copilot, Gemini, Google AI Mode, and Google AI Overviews).

WeightWatchers

Two high-severity factual conflicts were detected for WeightWatchers, both on the topic of the number-one weight loss program ranking. When asked "What is the #1 weight loss program?", Google AI Mode stated that WeightWatchers is historically and frequently ranked as the number-one best commercial diet and weight-loss program by expert panels, citing ABC News and the company's own announcement of its U.S. News recognition. Copilot, responding to the same question, stated that Noom is the number-one weight loss program in 2026, ranked best overall by multiple expert reviews, citing Fortune, RealComparisons, and BestGuide. Both responses identify a single number-one overall program but name different companies, so they cannot both be true. Flagged sources included the U.S. News WeightWatchers diet page on the WeightWatchers side and the Fortune article "7 Best Weight Loss Programs (2026)" on the Copilot side.

A second high-severity conflict on the same topic saw Google AI Overviews state that WeightWatchers is ranked number-one Best Overall Diet and Best for Fast Weight Loss by U.S. News & World Report, citing the U.S. News health page on best weight-loss diets, a Grampians Weight Specialists page, and the Mayo Clinic diet page. Copilot again stated that Noom is the number-one weight loss program in 2026, citing Fortune, RealComparisons, and BestGuide. The flagged sources included a U.S. News reference stating WeightWatchers ranked number-one and a Fortune reference naming Noom as the top pick, illustrating that AI platforms are drawing from different ranking authorities when answering the same query.

Hims

One high-severity factual conflict was detected for Hims regarding the medication types the company offers. When asked "What is the best online company for weight loss medication?", Gemini stated that Hims primarily offers FDA-approved brand-name medications, citing Healthy Living Clinic and Everyday Health. Copilot stated that Hims offers compounded medications only, citing U.S. News and GLP1Clinics.org. The two claims are mutually exclusive: Hims cannot both primarily offer brand-name medications and offer compounded medications only. A flagged source on the Gemini side referenced how large brands like Ro and Hims & Hers have shifted toward branded Wegovy and Zepbound after exiting compounded semaglutide.

LifeMD

One high-severity pricing conflict was detected for LifeMD regarding the monthly membership fee. When asked "Is LifeMD for weight loss legit?", Gemini stated that the monthly program fee is typically about $75 for the first month and around $149 per month thereafter, citing Healthline, Woman's World, and the Better Business Bureau. Copilot stated that the monthly membership fee is $149 to $499 without insurance, citing U.S. News, GLP-1 Reviews, and GLP1Zoom. The two answers give incompatible monthly fee structures for the same company, so they cannot both accurately describe the same pricing. Flagged sources included a Healthline excerpt stating the program starts at $75 for the first month and $149 thereafter, and a CravingWise excerpt describing pricing from $149 per month with a $39 first month and medication billed separately.

Benchmark Context

Questions This Section Answers

• How does the qualification funnel reduce 800 prompts to the benchmark denominator?
• Why do brand-level percentages rest on a smaller qualified observation set than the raw collection?

The report separates the raw collection universe from the qualified analysis set. Brand-level recommendation percentages are calculated within the qualified benchmark set of 170 observations in July 2026 and 255 in October 2026.

These two layers work together: the qualification funnel determines which prompts feed the brand-level metrics, while the benchmark-level figures below summarize how the qualified set behaved overall.

Benchmark-Level Metrics

The relevant-prompt rate held near 62% in October 2026 (495 of 800), well above the 298 of 800 recorded in July 2026. The qualified observation count settled at 255 after September's 286, so the October figures rest on a slightly narrower base than the prior month, while the recommendation-shaped answer share and valid recommendation shortlist share both climbed to their highest levels in the series.

AI Recommendation Trend

Questions This Section Answers

• Who leads the weight loss category in valid recommendation coverage, and where do the other brands land?
• Which brands qualified as significant risers or decliners between July and October 2026?

Valid Recommendation Coverage by Brand

WeightWatchers retains the lead, but the upper tier has broadened: Noom and Ro are now tied in second, and Found has closed most of the gap to third with a 13.5-point single-month rise.

Movement from the July 2026 baseline to October 2026 shows five brands placed as significant risers: Found, Hims, LifeMD, Ro, and WeightWatchers all exceeded their normal month-to-month variation thresholds. Ro (Roman) is the only significant decliner. Several of the category-level changes came from the combination of smaller movements across GNC, Vitamin Shoppe, and Herbalife, none of which crossed the significance threshold on the primary metric.

What Changed This Month

Questions This Section Answers

• Which brand made the largest single-month move in October 2026, and why is it a shortlist inclusion story rather than a top-slot displacement?
• What separates the top-slot strength of WeightWatchers, Noom, and Ro from Found's broader coverage gain?
• Why should the Ro (Roman) and Ro line items be read as a discontinuity rather than continuous movement?

WeightWatchers: Extending the Lead as the Field Broadens

WeightWatchers' valid recommendation coverage rose from 46.9% in September 2026 to 54.1% in October 2026, a 7.2-point gain that does not cross the significance threshold against the prior month. Against the July 2026 baseline of 41.2%, the four-month change is a 12.9-point rise that the benchmark does classify as significant, placing WeightWatchers among the month's significant risers.

Placement quality reinforces the coverage position. WeightWatchers recorded 104 top-three placements in October 2026 and 49 rank-one placements, the highest absolute counts in the category. Its rank-one rate of 19.2% is up 8.6 points from the July 2026 baseline of 10.6%. Raw mention presence reached 68.6% in October 2026, up from 61.2% in July 2026.

The distinction to hold: WeightWatchers is winning on both visible presence and top-slot placement simultaneously, and on a qualified base of 255 observations the absolute counts behind its percentages are the largest in the category. There is no small-count caveat to apply here.

Highest-priority diagnostic: whether WeightWatchers' rank-one strength is concentrated in the highest-intent prompts or distributed broadly across the category, and which competing brand takes the top slot when WeightWatchers is not first.

Ro: A Two-Month Streak Consolidates the Position

Ro's valid recommendation coverage rose from 32.9% in September 2026 to 49.4% in October 2026, a 16.5-point gain, following the 32.9-point rise recorded into September. Against the July 2026 baseline, the movement is up 49.4 points and the benchmark classifies it as a significant riser with a two-month upward streak.

Placement figures confirm the coverage. Ro recorded 89 top-three placements and 41 rank-one placements in October 2026, second only to WeightWatchers on both counts. Its rank-one rate of 16.1% is close to WeightWatchers' 19.2%. Raw mention presence reached 64.7%.

The distinction: Ro's series begins at zero in July and August 2026 because the entity was tracked under the name "Ro (Roman)" until September 2026. The benchmark records these as separate line items. The commercial signal is that a specific tracked entity now holds top-three placement in roughly one of every three qualified observations in October 2026.

Highest-priority diagnostic: which prompt categories and AI surfaces account for Ro's rank-one placements, and whether those are prompts where WeightWatchers and Noom also appear or prompts Ro now holds alone.

Found: The Sharpest Single-Month Move

Found's valid recommendation coverage rose from 24.5% in September 2026 to 38.0% in October 2026, a 13.5-point gain that is the largest single-month move in the category this month and crosses the significance threshold. Against the July 2026 baseline of 22.9%, the change is up 15.1 points.

Placement improved alongside coverage. Found's top-three rate rose from 13.5% at baseline to 23.9% in October 2026, and its rank-one rate moved from zero at baseline to 3.5% in October 2026. The brand recorded 61 top-three placements and 9 rank-one placements in October 2026. Raw mention presence reached 40.8%.

The distinction: Found's coverage growth is broader than its rank-one growth. The brand is being added to recommendation lists at a significantly higher rate than it is being placed first, so the commercial picture is one of expanded shortlist inclusion rather than top-slot displacement.

Highest-priority diagnostic: whether Found's new top-three placements are coming from prompts previously held by GNC and Vitamin Shoppe, or from prompts that grew the overall recommendation set.

Noom: Rank-One Strength Against a Coverage Story

Noom's valid recommendation coverage rose from 38.1% in September 2026 to 49.4% in October 2026, an 11.3-point gain the benchmark marks as significant against the prior month. Against the July 2026 baseline of 41.8%, the four-month change is up 7.6 points, which falls within normal variation and keeps the brand's overall classification stable.

Placement remained strong. Noom recorded 94 top-three placements and 36 rank-one placements in October 2026. Its rank-one rate of 14.1% is down 5.9 points from the July 2026 baseline of 20.0%. Raw mention presence reached 57.6%.

The distinction: Noom's coverage gain this month was partly a recovery from its September trough, and the brand's rank-one rate has drifted down from its baseline even as coverage grew. Noom appears in more shortlists than in July 2026 but holds the top slot in a smaller share of them.

Highest-priority diagnostic: which surfaces drove Noom's September-to-October coverage recovery, and whether the rank-one drift is concentrated in prompts where Ro now competes.

Hims and LifeMD: Mid-Tier and Low-Count Risers

Hims' valid recommendation coverage rose from 13.5% in July 2026 to 21.2% in October 2026, a 7.7-point gain the benchmark classifies as significant, with a two-month upward streak. The September-to-October move was an 8.3-point gain from 12.9%, also significant. The brand recorded 29 top-three placements in October 2026 and 1 rank-one placement.

LifeMD's coverage rose from 1.2% in July 2026 to 4.7% in October 2026, a 3.5-point gain classified as significant, following a 4.0-point September-to-October gain from 0.7%. The brand recorded 12 valid recommendations out of 255 qualified observations in October 2026.

The distinction: LifeMD's percentages move in large relative swings on very small absolute counts. The 3.5-point baseline-to-current gain reflects 12 valid recommendations in October 2026, so the commercial read is early presence rather than an established position.

Highest-priority diagnostic: whether Hims' top-three placements are concentrated on surface families where it appears alongside Ro and WeightWatchers, and which prompts produced LifeMD's twelve October placements.

Ro (Roman) and Herbalife: Zero-Coverage Line Items

Ro (Roman) recorded zero valid recommendation coverage in October 2026, unchanged from September 2026 and down 17.6 points from the July 2026 baseline of 17.6%. The benchmark classifies the entity as a significant decliner. Its raw mention presence is null in the current month.

Herbalife recorded zero valid recommendation coverage for the third consecutive month, down 1.2 points from the July 2026 baseline of 1.2%. Raw mention presence was 1.6% in October 2026, reflecting 4 present observations out of 255 qualified.

The distinction: Ro (Roman) and Ro remain separate line items in the benchmark, and readers should treat the naming change as a discontinuity rather than continuous movement for a single tracked entity. Herbalife's zero-coverage run reflects a small absolute footprint, and the percentages rest on counts of four or fewer.

Highest-priority diagnostic: which prompts previously produced recommendations for the Ro (Roman) line item and for Herbalife, and which brands now appear in those responses.

GNC and Vitamin Shoppe: Low-Level Retail Presence

GNC's valid recommendation coverage held at 2.4% in October 2026, up 0.6 points from 1.8% in September 2026 but down 4.1 points from the July 2026 baseline of 6.5%, a change the benchmark does not classify as significant. Raw mention presence fell from 31.2% in July 2026 to 12.9% in October 2026, a decline of 18.3 points. GNC recorded 6 valid recommendations out of 255 qualified observations in October 2026.

Vitamin Shoppe's coverage held at 2.4% in October 2026, up 0.6 points from 1.8% in September 2026 and down 2.9 points from the July 2026 baseline of 5.3%, not classified as significant. Raw mention presence fell from 25.3% at baseline to 10.6% in October 2026, a decline of 14.7 points. Vitamin Shoppe recorded 6 valid recommendations in October 2026, all of them rank-one placements.

The distinction: both retail brands show stable-to-slightly-improved recommendation coverage against September on very small absolute counts, while their visible mention presence has fallen since July 2026. The retail cluster remains present in AI responses but increasingly outside the recommendation shortlist.

Highest-priority diagnostic: whether the retail cluster's presence decline is concentrated on specific surface families or reflects a change in the prompt mix toward clinical and program-based brands.

Buyer-Intent Interpretation

Questions This Section Answers

• Which buyer-intent clusters did the October 2026 qualified observations fall into?
• Why can the public benchmark not yet speak to pricing, value, or head-to-head comparisons?

All 255 qualified observations in October 2026 fell into the Brand Recommendation cluster. None of the qualified prompts were classified under Pricing & Value or Multi-Brand Comparison, and the same pattern held across the July, August, and September 2026 readings. The pricing analysis response type did appear in the raw response distribution, but none of those observations qualified for the benchmark's public set this month.

The public benchmark currently answers which brands AI systems recommend, but it cannot yet speak to pricing, value, or head-to-head comparison. Those commercial questions remain open for company-level analysis. The AI response inconsistency data supplied this month shows that pricing conflicts do exist beneath the surface of these responses, but they sit outside the qualified recommendation set the public benchmark measures.

Brand Opportunity Summary

Questions This Section Answers

• Which brand-specific diagnostics does the benchmark flag as highest priority for each tracked company?
• What signals distinguish the leading brands from the mid-tier risers and the zero-coverage line items?

The benchmark identifies where attention is warranted; a company-level analysis is needed to explain why.

Evidence Behind the Benchmark

The aggregate metrics are built from prompt-level observations covering the query, the AI surface used, the recommendation outcome, ranking position, sentiment, and citations where exposed. Company-level analysis can go deeper into the specific prompts where a brand wins or loses, which competitors take the recommendation when a brand is absent, and which external sources shape the AI responses. Source presence is not automatically treated as proof of causation.

About This Benchmark

This report is part of CiteWorks Studio's AI Visibility Market Discovery research program.

• AI Visibility Industry Market Methodology
• AI Visibility Industry Market Metrics
• AI Visibility Industry Market Standards

Report-Specific Interpretation Notes

• The qualified benchmark set (255 observations in October 2026) is smaller than the raw collection of 800 prompts per month. Brand-level percentages are calculated within the qualified set, so small counts for brands like Herbalife, LifeMD, GNC, and Vitamin Shoppe should be read with caution.
• The entity tracked as "Ro (Roman)" in July and August 2026 no longer appears under that name from September 2026 onward, while an entity named "Ro" appears for the first time in September 2026. The benchmark tracks these as separate line items; readers should treat the naming change as a discontinuity rather than continuous single-entity movement when interpreting the series.
• The four-month series remains early in its tracking history, and the observation count has moved across the period (170 in July 2026, 190 in August 2026, 286 in September 2026, and 255 in October 2026), changing the comparison base. Movement identifies where attention is warranted; it does not by itself establish the cause of those changes.

Next Step

The Public Benchmark Shows Where a Brand Is Winning or Losing. A Company-Level Audit Shows Why.

The aggregate percentages answer which brands AI systems recommend, but they leave the most important questions open: which high-intent prompts a brand wins, which competitor takes the recommendation when a brand loses, what attributes AI systems associate with each option, and which external sources shape those answers. A brand like Found can rise 13.5 points in a single month without the benchmark explaining which prompts the new placements came from, and platforms can disagree on something as basic as which program is ranked number one. Those distinctions carry very different commercial consequences.

A company-specific AI visibility audit maps those prompt, surface, competitor, ranking, sentiment, and evidence-source patterns into a prioritized visibility strategy. It identifies the specific gaps between where a brand sits in AI recommendations and where it could sit, based on the full evidence trail behind each response.

Request an AI visibility audit